Skip to main content
Log in

Malignant hyperthermia susceptibility in a patient with mitochondrial disorder

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Occasionally, patients with mitochondrial disorder (MID) develop malignant hyperthermia (MH)-like reactions or show an abnormal halothane-caffeine in-vitro contracture test. In a 66 year old Caucasian male with facial dysmorphism, epilepsy, chronic muscle cramps, repeatedly elevated creatine-kinase, Dupuytren contracture, and hypertrophic cardiomyopathy, a MID was found upon the clinical presentation, blood chemical investigations, and the muscle biopsy findings. Upon request of the anesthesiologists prior to surgery of a hernia cicatrices a halothane-caffeine in-vitro contracture test was carried out according to the protocol of the European MH Group (EMHG), showing abnormal hypercontractility to halothane and caffeine, resulting in the diagnosis susceptible MH according to the EMHG guidelines. Subsequent general anesthesia was carried out without complications by avoiding volatile anesthetics and succinylcholine. In the past the patient had already tolerated four procedures under general anesthesia, without any complication. MIDs may be associated with an abnormal halothane-caffeine in-vitro contracture test. Though previous general anesthesias had been carried out without major complications, it cannot be ruled out that MH-like manifestations may develop during future anesthesias if trigger agents are not avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Breucking E et al (1993) Anesthesia and intensive therapy for a patient with mitochondrial myopathy. Anaesthesist 42:719–723

    CAS  PubMed  Google Scholar 

  • Cheam EW, Critchley LA (1998) Anesthesia for a child with complex I respiratory chain enzyme deficiency. J Clin Anesth 10:524–527

    Article  CAS  PubMed  Google Scholar 

  • Etcharry-Bouyx F et al (1995) Chronic rhabdomyolysis disclosing mitochondriopathy and malignant hyperthermia susceptibility. Rev Neurol. (Paris) 151:589–592

    CAS  Google Scholar 

  • Figarella-Branger D et al (1993) Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord 3:553–556

    Article  CAS  PubMed  Google Scholar 

  • Finsterer J (2003) Current concepts in malignant hyperthermia. J Clin Neuromusc Dis 4:64–74

    Article  Google Scholar 

  • Footitt EJ et al (2008) Mitochondrial disorders and general anaesthesia: a case series and review. Br J Anaesth 100:436–441

    Article  CAS  PubMed  Google Scholar 

  • Fricker RM et al (2002) Positive malignant hyperthermia susceptibility in-vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiology 97:1635–1637

    Article  PubMed  Google Scholar 

  • Heinke W, Schaffranietz L (2004) Anaesthesia for combined pancreatic and renal transplantation in a patient with mitochondrial encepahalomyopathy—a case report. Anaesthesiol Reanim 29:87–90

    CAS  PubMed  Google Scholar 

  • Itaya K et al (1995) Anesthetic management of two patients with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Masui 44:710–712

    CAS  PubMed  Google Scholar 

  • Lehmann-Horn F, Iaizzo PA (1990) Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? Br J Anaesth 65:692–697

    Article  CAS  PubMed  Google Scholar 

  • Ording H et al (1997) In-vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 41:955–966

    Article  CAS  PubMed  Google Scholar 

  • Rosaeg OP et al (1996) Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can J Anaesth 43:403–407

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg H et al (2007) Malignant hyperthermia. Orphanet J Rare Dis 2:21–33

    Article  PubMed  Google Scholar 

  • Thiel A et al (2001) Anesthesia in mitochondrial encephalomyopathies. Anasthesiol Intensivmed Notfallmed Schmerzther 36:437–439

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

The authors want to thank Hermann Gilly PhD (Department of Special Anesthesia and Pain Therapy, Medical University of Vienna, Austria) for the preparation of Fig. 2.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josef Finsterer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finsterer, J., Michalek-Sauberer, A. & Höftberger, R. Malignant hyperthermia susceptibility in a patient with mitochondrial disorder. Metab Brain Dis 24, 501–506 (2009). https://doi.org/10.1007/s11011-009-9148-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-009-9148-3

Keywords

Navigation